Advisor Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $6.09M | Buy |
65,769
+3,968
| +6% | +$387K | 0.43% | 42 |
|
|
2022
Q1 | $6.25M | Sell |
61,801
-42
| -0.1% | -$4.41K | 0.39% | 44 |
|
|
2021
Q4 | $6.38M | Buy |
61,843
+1,155
| +2% | +$107K | 0.38% | 47 |
|
|
2021
Q3 | $5.15M | Sell |
60,688
-148
| -0.2% | -$12.4K | 0.35% | 52 |
|
|
2021
Q2 | $5.08M | Buy |
60,836
+1,520
| +3% | +$124K | 0.33% | 58 |
|
|
2021
Q1 | $4.46M | Buy |
59,316
+1,097
| +2% | +$79.9K | 0.32% | 60 |
|
|
2020
Q4 | $3.98M | Buy |
58,219
+2,222
| +4% | +$145K | 0.3% | 62 |
|
|
2020
Q3 | $3.27M | Sell |
55,997
-6,356
| -10% | -$395K | 0.28% | 64 |
|
|
2020
Q2 | $4.05M | Buy |
62,353
+9,565
| +18% | +$602K | 0.38% | 54 |
|
|
2020
Q1 | $3.13M | Buy |
52,788
+2,721
| +5% | +$182K | 0.38% | 55 |
|
|
2019
Q4 | $3.77M | Buy |
50,067
+9,866
| +25% | +$693K | 0.39% | 58 |
|
|
2019
Q3 | $2.54M | Buy |
40,201
+5,930
| +17% | +$351K | 0.31% | 67 |
|
|
2019
Q2 | $1.87M | Buy |
34,271
+9,807
| +40% | +$528K | 0.23% | 87 |
|
|
2019
Q1 | $1.32M | Sell |
24,464
-19,193
| -44% | -$1.18M | 0.17% | 115 |
|
|
2018
Q4 | $2.86M | Buy |
43,657
+13,253
| +44% | +$989K | 0.46% | 47 |
|
|
2018
Q3 | $2.39M | Buy |
30,404
+2,469
| +9% | +$177K | 0.32% | 60 |
|
|
2018
Q2 | $1.8M | Buy |
27,935
+7,485
| +37% | +$493K | 0.3% | 70 |
|
|
2018
Q1 | $1.27M | Sell |
20,450
-5,316
| -21% | -$381K | 0.24% | 93 |
|
|
2017
Q4 | $2.06M | Sell |
25,766
-1,929
| -7% | -$140K | 0.37% | 55 |
|
|
2017
Q3 | $2.25M | Buy |
27,695
+703
| +3% | +$55.6K | 0.44% | 47 |
|
|
2017
Q2 | $2.17M | Buy |
26,992
+2,380
| +10% | +$188K | 0.51% | 41 |
|
|
2017
Q1 | $1.93M | Buy |
24,612
+4,660
| +23% | +$372K | 0.51% | 41 |
|
|
2016
Q4 | $1.57M | Sell |
19,952
-569
| -3% | -$46K | 0.47% | 47 |
|
|
2016
Q3 | $1.83M | Sell |
20,521
-3,724
| -15% | -$352K | 0.61% | 39 |
|
|
2016
Q2 | $2.32M | Buy |
24,245
+151
| +0.6% | +$15K | 0.81% | 27 |
|
|
2016
Q1 | $2.5M | Sell |
24,094
-772
| -3% | -$75.1K | 0.93% | 23 |
|
|
2015
Q4 | $2.43M | Sell |
24,866
-2,307
| -8% | -$226K | 0.83% | 31 |
|
|
2015
Q3 | $2.64M | Buy |
27,173
+272
| +1% | +$28.6K | 1.11% | 17 |
|
|
2015
Q2 | $2.79M | Buy |
26,901
+2,402
| +10% | +$245K | 1.07% | 12 |
|
|
2015
Q1 | $2.53M | Sell |
24,499
-1,241
| -5% | -$126K | 1.07% | 11 |
|
|
2014
Q4 | $2.41M | Buy |
25,740
+740
| +3% | +$65.2K | 1.06% | 14 |
|
|
2014
Q3 | $1.99M | Buy |
25,000
+818
| +3% | +$64.5K | 1.14% | 20 |
|
|
2014
Q2 | $1.82M | Buy |
24,182
+1,276
| +6% | +$96.4K | 0.9% | 24 |
|
|
2014
Q1 | $1.72M | Buy |
22,906
+274
| +1% | +$19.4K | 0.94% | 21 |
|
|
2013
Q4 | $1.62M | Buy |
22,632
+1,454
| +7% | +$93.4K | 0.93% | 23 |
|
|
2013
Q3 | $1.2M | Buy |
21,178
+933
| +5% | +$55.6K | 0.86% | 32 |
|
|
2013
Q2 | $1.16M | Buy |
+20,245
| New | +$1.17M | 0.95% | 26 |
|
Other funds holding CVS
Advisor Partners's CVS Position: Q2 2022 in Review
Advisor Partners increased its CVS Health (CVS) stake by 6.4% in Q2 2022, buying an estimated $387K and bringing the position to 65,769 shares worth $6.09M. The position accounts for 0.43% of the portfolio, ranked #42.
Advisor Partners first reported a position in CVS in Q2 2013 and has held it in 37 quarters since. The position peaked at $6.38M in Q4 2021. 2,308 funds tracked by Wall St. Rank hold CVS as of Q2 2022.
- Advisor Partners held 65,769 shares of CVS Health worth $6.09M as of Q2 2022.
- Advisor Partners bought 3,968 CVS Health shares in Q2 2022, an estimated $387K.
- CVS Health made up 0.43% of Advisor Partners's portfolio in Q2 2022, its #42 holding.
- Advisor Partners first reported a position in CVS Health in Q2 2013 and has held it in 37 quarters since.
- Advisor Partners's CVS Health position peaked at $6.38M in Q4 2021.
- 2,308 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.